Bicycle Therapeutics: Q4 Earnings Insights

 

Bicycle Therapeutics BCYC reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Bicycle Therapeutics missed estimated earnings by 3.28%, reporting an EPS of $-0.63 versus an estimate of $-0.61.

Revenue was up $77.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 0.07% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCYC Logo
BCYCBicycle Therapeutics PLC
$7.420.13%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
5.36
Growth
Not Available
Quality
Not Available
Value
46.23
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...